Use of the Palliative Performance Scale to estimate survival among home hospice patients with heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 20 07 2018
accepted: 23 11 2018
pubmed: 6 3 2019
medline: 17 5 2019
entrez: 6 3 2019
Statut: ppublish

Résumé

Estimating survival is challenging in the terminal phase of advanced heart failure. Patients, families, and health-care organizations would benefit from more reliable prognostic tools. The Palliative Performance Scale Version 2 (PPSv2) is a reliable and validated tool used to measure functional performance; higher scores indicate higher functionality. It has been widely used to estimate survival in patients with cancer but rarely used in patients with heart failure. The aim of this study was to identify prognostic cut-points of the PPSv2 for predicting survival among patients with heart failure receiving home hospice care. This retrospective cohort study included 1114 adult patients with a primary diagnosis of heart failure from a not-for-profit hospice agency between January 2013 and May 2017. The primary outcome was survival time. A Cox proportional-hazards model and sensitivity analyses were used to examine the association between PPSv2 scores and survival time, controlling for demographic and clinical variables. Receiver operating characteristic curves were plotted to quantify the diagnostic performance of PPSv2 scores by survival time. Lower PPSv2 scores on admission to hospice were associated with decreased median (interquartile range, IQR) survival time [PPSv2 10 = 2 IQR: 1-5 days; PPSv2 20 = 3 IQR: 2-8 days] IQR: 55-207. The discrimination of the PPSv2 at baseline for predicting death was highest at 7 days [area under the curve (AUC) = 0.802], followed by an AUC of 0.774 at 14 days, an AUC of 0.736 at 30 days, and an AUC of 0.705 at 90 days. The PPSv2 tool can be used by health-care providers for prognostication of hospice-enrolled patients with heart failure who are at high risk of near-term death. It has the greatest utility in patients who have the most functional impairment.

Identifiants

pubmed: 30835970
doi: 10.1002/ehf2.12398
pmc: PMC6437549
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

371-378

Subventions

Organisme : NINR NIH HHS
ID : R00 NR016275
Pays : United States
Organisme : NINR NIH HHS
ID : T32 NR007969
Pays : United States
Organisme : NINR NIH HHS
ID : T32NR007969
Pays : United States
Organisme : NINR NIH HHS
ID : R00NR016275
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

Palliat Med. 2007 Mar;21(2):95-9
pubmed: 17344257
J Palliat Care. 1996 Spring;12(1):5-11
pubmed: 8857241
Circ Heart Fail. 2013 Sep 1;6(5):881-9
pubmed: 23888045
BMJ. 2000 Feb 19;320(7233):469-72
pubmed: 10678857
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
Circulation. 2012 Apr 17;125(15):1928-52
pubmed: 22392529
J Palliat Med. 2005 Jun;8(3):503-9
pubmed: 15992191
J Palliat Med. 2015 Jan;18(1):67-70
pubmed: 25122510
J Palliat Med. 2010 May;13(5):549-57
pubmed: 20377498
Eur Heart J. 2013 May;34(19):1404-13
pubmed: 23095984
J Pain Symptom Manage. 2009 Apr;37(4):642-8
pubmed: 18823751
J Pain Symptom Manage. 2009 Jun;37(6):965-72
pubmed: 19232892
J Palliat Care. 2007 Winter;23(4):245-52; discussion 252-4
pubmed: 18251442
J Pain Symptom Manage. 2009 Jul;38(1):134-44
pubmed: 19171459
ESC Heart Fail. 2019 Apr;6(2):371-378
pubmed: 30835970
Am J Cardiol. 2007 Aug 15;100(4):697-700
pubmed: 17697831
Curr Opin Cardiol. 2018 Mar;33(2):202-207
pubmed: 29135524
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
JAMA Cardiol. 2017 Apr 1;2(4):435-441
pubmed: 28002546
Am J Surg. 2017 Apr;213(4):778-784
pubmed: 28160967
Curr Cardiol Rev. 2018;14(2):128-137
pubmed: 29366424
Palliat Med. 2016 Jul;30(7):684-9
pubmed: 26769732
Palliat Med. 2013 Apr;27(4):367-74
pubmed: 22760474
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
J Palliat Med. 2014 Aug;17(8):894-8
pubmed: 24922330
J Palliat Med. 2018 Nov;21(11):1651-1661
pubmed: 30129809
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
BMC Palliat Care. 2008 Aug 04;7:10
pubmed: 18680590
Palliat Med. 2018 Oct 1;:269216318804456
pubmed: 30269647
J Pain Symptom Manage. 2017 May;53(5):962-970.e10
pubmed: 28062344

Auteurs

Ruth Masterson Creber (R)

Division of Health Informatics, Department of Healthcare Policy and Research, Weill Cornell Medicine, 425 East Street, Suite 301, New York, NY, 10065, USA.

David Russell (D)

Visiting Nurse Service of New York, New York, NY, 10021, USA.
Appalachian State University, Boone, NC, 28608, USA.

Frances Dooley (F)

Visiting Nurse Service of New York, New York, NY, 10021, USA.

Lizeyka Jordan (L)

Visiting Nurse Service of New York, New York, NY, 10021, USA.

Dawon Baik (D)

Columbia University School of Nursing, New York, NY, 10032, USA.

Parag Goyal (P)

Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.

Scott Hummel (S)

Department of Medicine, University of Michigan, Ann Arbor Veterans Affairs Health System, Ann Arbor, MI, 48105, USA.

Ellen K Hummel (EK)

Department of Medicine, University of Michigan, Ann Arbor Veterans Affairs Health System, Ann Arbor, MI, 48105, USA.

Kathryn H Bowles (KH)

University of Pennsylvania School of Nursing, Philadelphia, PA, 19104, USA.
Center for Home Care Policy and Research, Visiting Nurse Service of New York, New York, NY, 10021, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH